4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-26-112058
Chief Financial Officer sold 3,377 shares at $36.57 ($123,497)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts Brandi Chief Financial Officer | 2026-09-25 | Sale 10b5-1 | −3,377 | $36.57 | $123,497 | 394,528 | D: show line 1 in the form |
| Open-market sales · 3,377 sh · avg $36.57 · $123,497 | |||||||
Loading xslF345X06/tm2626627-1_4seq1.xml…